Consumer Health AI Governance

Consumer health AI governance is the source’s boundary between informational wellness tools and regulated medical intervention. In Supercharging a New FDA: Marty Makary on Science, Power & Patients, Marty Makary says AI produces information faster than traditional regulatory systems can keep up, so the FDA should distinguish consumer information tools from automated AI that triggers health interventions.

The episode uses wearables as the practical case. Devices can report physiological parameters, but Makary says “medical grade” claims require validation against gold-standard measurements, especially when outputs might affect diagnosis, treatment, or escalation.

Key Claims

• Consumer information and clinical intervention should sit in different regulatory lanes.
• “Medical grade” is a claim about validation, not just sensor sophistication or AI-generated confidence.
• Regulatory guidance has to move faster because AI health features can be deployed and updated quickly.
• The concept connects to Medical AI Workflow Integration but focuses on consumer tools rather than hospital back-office or physician-supervised workflows.

Connections

• FDA and Marty Makary - agency and source speaker.
• FDA Review Modernization - regulatory-speed context.
• Medical AI Workflow Integration, Healthcare AI Infrastructure, and AI Verification - adjacent AI healthcare and verification concepts.
• Fitbit AI Health Coach, ChatGPT Health, and HealthBench - existing AI-health entities relevant to consumer or evaluation boundaries.